| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 75,000 | 01 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2025 | 1 | $0 | 4 | Director | 02 Jul 2025, 21:00 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2024 | 1 | $0 | 4 | Director | 03 Jul 2024, 17:00 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2023 | 1 | $0 | 4 | Director | 03 Jul 2023, 17:46 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 06 Jul 2022, 16:15 |
| LCTX | Lineage Cell Therapeutics, Inc. | 28 Mar 2022 | 1 | +$57,050 | 4 | Director | 29 Mar 2022, 16:15 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 01 Jul 2021, 18:26 |